Latest KFF Health News Stories
Pioneering Cancer Gene Therapy Gets Green Light — And $475,000 Price Tag
The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
5 ideas controversiales para arreglar el mercado de seguros individual
Desde modificar la edad de ingreso al Medicare, hasta tener un Medicaid “a la carta”, estas ideas están sonando y generando polémica en los pasillos del Congreso.
5 Outside-The-Box Ideas For Fixing The Individual Insurance Market
As lawmakers look for ways to stabilize the health law marketplaces, a number of ideas — such as expanding who can “buy in” to Medicare and Medicaid or pushing young adults off their parents’ plans into the marketplaces — might come into play.
Facebook Live: The Prescription Drug Pricing Pipeline
In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.
En la Clínica Mayo enseñan a controlar el dolor sin opioides
Un programa que ya ha cumplido 40 años ayuda a personas con dolor crónico a mejorar sus vidas sin tomar medicamentos que pueden ser adictivos.
Mayo Pain Expert: Holistic Approach Helps Patients Ditch Opioids
Painkillers were never designed to be used over the long term, says the head of the Mayo Clinic’s pain rehabilitation center. Instead, patients should try other approaches, including relaxation therapies. But getting insurers to cover them might take coaxing.
Polémica por ensayo de una vacuna contra el herpes en el extranjero
El ensayo clínico de una vacuna contra el herpes común fuera de los Estados Unidos ha generado una controversia médica y una investigación gubernamental.
Offshore Human Testing Of Herpes Vaccine Stokes Debate Over U.S. Safety Rules
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
Elder Abuse: ERs Learn How To Protect A Vulnerable Population
An emergency department at New York-Presbyterian Hospital trains staff to recognize signs of elder abuse and help victims.
What Happens If You’re Forced To Switch Health Plans When You’re Sick?
State lawmakers in California have an answer: legislation that would require your new insurer to keep paying for your current doctors even if they’re not in the network.
Cáncer: cuando escribir ayuda a sanar
A través de la escritura expresiva, pacientes con cáncer logran canalizar sus miedos y ansiedades, y contar sus historias, en un inédito proceso creativo.
¿Qué pasa si debes cambiar de plan de salud… estando enfermo?
El retiro de algunas aseguradoras del mercado ha obligado a miles de consumidores a cambiar de plan. Algo que se complica en el caso de pacientes con condiciones crónicas o graves.
Writing Your Way Through Cancer
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
Después de Charlottesville: por qué las personas se unen a grupos de odio
Hay 917 grupos de odio conocidos en los Estados Unidos, un número que ha ido aumentando en los últimos dos años, según datos del Southern Poverty Law Center.
Podcast: ‘What The Health?’ Back To Health Crunch Come September
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Margot Sanger-Katz of The New York Times discuss the continuing efforts in Congress to “repeal and replace” the Affordable Care Act, upcoming open enrollment for individual insurance and Congress’ long health care to-do list for September.
Charlottesville Postmortem: Why People Join Hate Groups
Unhappy childhood experiences can drive people to join white supremacist groups, studies have found.
Will GOP Pay A Price For Trying To Take Health Care Benefits From Voters?
Politicians who tried to take health care benefits from their voters may face political consequences as constituents come to understand what’s at stake — in a way they didn’t a few months ago.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Dying At Home In An Opioid Crisis: Hospices Grapple With Stolen Meds
As more patients receive hospice care at home, some of the powerful, addictive drugs they’re prescribed are ending up in the wrong hands.